VDJ
company
About
VDJ engages in the R&D of monoclonal antibody drugs.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥20M
- Industries
- Biotechnology,Medical,Pharmaceutical
- Founded date
- Jul 20, 2011
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
¥56M
VDJ has raised a total of
¥56M
in funding over 2 rounds. Their latest funding was raised on
Jul 3, 2018 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 3, 2018 | Series C | ¥30M | 1 |
|
— | Detail |
| Dec 13, 2017 | Series B | ¥20M | 1 |
|
— | Detail |
| Sep 30, 2016 | Series A | ¥3M | 1 | — | — | Detail |
| Jun 4, 2014 | Angel | ¥3M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
4
VDJ is funded by 4 investors.
Beijing Youhe Dingxin Equity Investment Management
and Beijing Hankang Chuangye Touzi
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series C |
|
|
Yes | Series B |
|
|
— | Series A |
KMT Technology
|
— | Angel |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
